News & events


HSRC and Nabio Consulting HIV and TB Nanomedicine 4.0 Policy Dialogue 2019

29 October 2019
10:00 - 15:00

Download the presentations below:

Date: 29 October 2019
Time: 10h00 – 15h00
Venues in Pretoria, Durban and Cape Town (Videoconferencing facilities)

HIV/AIDS remains one of the world’s most significant public health challenges, particularly in low- and middle-income countries. South Africa ranks among the worst afflicted countries in the world for both HIV infection and tuberculosis (TB). An estimated 7.5 million people living with HIV (PLHIV) in South Africa in 2018, increased when compared with past few years, and about 68% of them are on antiretroviral therapy (ART). The number of new HIV infections were about 222, 000 in 2018. 

TB remains the leading cause of death among PLHIV, accounting for around one in three AIDS-related deaths. Patients TB co-infected with HIV are very difficult to manage, resulting into TB drug resistance. If South African needs to achievement their targets on the fight against HIV and to end the AIDS epidemic by 2030, they need to prioritise on emerging disruptive technologies such nanomedicine as an intervention strategy. Nanomedicine is the application of nanotechnology in medicine.

In pharmaceutics, nanomedicine approach has exhibited clear benefits when compared to conventional medicines, including improved efficacy, bioavailability, dose response, personalisation, targeting efficiency and drug safety profile with a fewer side effects. In addition, nanomedicine approach could cut dose of HIV treatment in half, and also offer better HIV and TB diagnostics tools at very lower costs.

In this seminar, we are interested to explore existing challenges in the public healthcare system in deploying use of nanomedicine to improving drug efficacy, safety, and cost, and diagnostics tools in the Era of the Fourth Industrial Revolution (Industry 4.0), putting TB and HIV in a spotlight.

The topics of discussions will include;
The global burden of HIV/AIDS and TB
The current situation of  HIV/AIDS and TB in South Africa
Nanomedicine for drug delivery system and diagnostic of HIV and TB
Nanomedicine: promises and challenges for the future of public health
Nanomedicine Era and pharmaceutical industry perspectives
Nanomedicine ethics, regulation and policy issues

Kindly RSVP by 28 October  2019

Pretoria: HSRC Video Conference Room, 1st floor HSRC Library, 134 Pretorius Street, Pretoria.
Contact Arlene Grossberg  | T: (012) 302 2811  | E:
Cape Town: HSRC Video Conference Room, Merchant House 116-118 Buitengracht Street, Cape Town.
Contact Shouneez Khan| T: (021) 466 7948 | E:
Durban: HSRC Video Conference Room, The Atrium, 5th Floor, 430 Peter Mokaba Ridge, Berea, 4001.
Contact Ridhwaan Khan  | T: (031) 242 5400  | C: 083 788 2786  | E:  or Wiseman Mbambo |  E:

The HSRC seminar series is funded by the Department of Science and Innovation (DSI). The views and opinions expressed therein as well as findings and statements of the seminar series do not necessarily represent the views of the DSI